Infinium Global Research Clinical Chemistry Analyzer Market | Page 2
A latest report has been added to the wide database of Clinical Chemistry Analyzer Market by Infinium Global Research. This
report studies the Clinical Chemistry Analyzer Market by products (analyzers, reagents), test (basic metabolic panel,
electrolyte panel, liver panel, lipid profile, and renal profile), end user (academic research institutes, diagnostics laboratories,
hospitals and others) market status and outlook of global and major regions, from manufacturers, and end industries. The
objective of the study is to identify market sizes of different segments & countries in recent years and to forecast the values
for the next six years. Clinical Chemistry Analyzer Market provides opportunities in micro markets for stakeholders to invest
along with the detailed analysis of competitive landscape, latest trends, and product offerings of the major companies in the
Clinical Chemistry Analyzer Market. Moreover, clinical analyzer market is anticipated grow at a CAGR between 5.1% - 5.5%
over the period of 2017 to 2023. Clinical chemistry analyzers are the computers programmed devices used to determine and
analyze levels of sugar, protein, and sugar present in the blood. These devices bring precise result at possible least time,
because they are highly technologically advance and made for such purpose. Clinical chemistry tests are performed to
determine clinical situations including kidney function, liver function, and nutritional state. Furthermore, these tests are
commonly adopted to analyze clinical conditions such as hyperlipidemia, diabetes, and arteriosclerosis. The report provides
inclusive analysis of market volume covered by the clinical chemistry analyzer across the world. The global market size of
clinical chemistry analyzer was worth approximately USD 9 billion in 2014 and the global market is forecast to surpass USD X.X
billion by 2023. Moreover, clinical analyzer market is anticipated grow at a CAGR between 5.1% - 5.5% over the period of 2017
to 2023.
Market Insights
Global clinical chemistry analyzer market is expected to be driven by rapid growth in diagnostic market, increased spending in
healthcare and augmented incidents in life style diseases. Additionally, technological advancements, increased awareness of
healthcare and diagnostic tests amongst population are likely to support the growth in the global market. Similarly, rising
number of point of care testing capabilities are also expected to boost the growth of this market over the forecast period.
Moreover, usage of clinical chemistry analyzers in investing crimes is likely to boost the market size of the clinical chemistry
analyzers in the world market with rising number of crimes globally. However, high cost, and requirement of highly qualified
and trained personnel are some of the restraints that are likely to hamper the growth in this market over the forecast period.
Geographically, the North America is considered as the leading market and accounted for 60% in the market in 2014.
Emerging markets such as BRIC countries are likely to grow at the fastest CAGR over the forecast period. The report covers the
analysis of global as well as regional markets of clinical chemistry analyzer market.
Infinium Global Research